Research Alliance Corp III
- Close
- Oct 29, 2026 · +0.00%
- Market cap
- $91.90M
- 9.1M shares
- Filings
- 51
—
—
—Q3 2026
—Q3 2026
——
—
—Q1 2026
—Q3 2026
—- $91.90M
- —
- —
- —
- —
- —
FY2026 figures · derived
Price
Oct 29, 2026 · Official close
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
General And Administrative
No annual history for this metric yet.
| Period | Ended | Value | Kind | Source trail |
|---|
Pharmaceutical preparations
Research Alliance Corp III is the 294th largest of the 552 covered companies the SEC files under this code, by market cap. SIC 2834
CompanyRevenueGrowthNet marginMarket cap
PLYXPolaryx Therapeutics, Inc.———$94.2MHURATuHURA Biosciences, Inc.$0.0——$94.0MANIXAnixa Biosciences Inc———$93.2MPMVPPMV Pharmaceuticals, Inc.———$92.2M
RACCResearch Alliance Corp III (this company)———$91.9M
GNLXGenelux Corp$8.0K0.0%401,812.5%$91.6MNKTXNkarta, Inc.$0.0——$90.7MIFRXInflaRx N.V.———$89.6MKZIAKazia Therapeutics Ltd———$89.6MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Research Alliance Corp III · CIK 2118032 · Engraved from SEC EDGAR